PPA
FBIO icon

Parametric Portfolio Associates’s Fortress Biotech FBIO Stock Holding History

Parametric Portfolio Associates’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,345
Closed -$88K – 3700
2021
Q4 		$88K Buy
+2,345
New +$105K ﹤0.01% 3567
2018
Q4 		– Sell
-4,273
Closed -$103K – 3920
2018
Q3 		$103K Buy
4,273
+491
+13% +$15.7K ﹤0.01% 3842
2018
Q2 		$169K Sell
3,782
-185
-5% -$10.4K ﹤0.01% 3733
2018
Q1 		$271K Buy
3,967
+102
+3% +$6.46K ﹤0.01% 3608
2017
Q4 		$231K Sell
3,865
-44
-1% -$2.59K ﹤0.01% 3699
2017
Q3 		$259K Sell
3,909
-39
-1% -$2.63K ﹤0.01% 3748
2017
Q2 		$281K Buy
3,948
+127
+3% +$7.5K ﹤0.01% 3663
2017
Q1 		$212K Sell
3,821
-32
-0.8% -$1.43K ﹤0.01% 3577
2016
Q4 		$156K Buy
3,853
+73
+2% +$2.73K ﹤0.01% 3645
2016
Q3 		$168K Sell
3,780
-33
-0.9% -$1.4K ﹤0.01% 3613
2016
Q2 		$154K Buy
3,813
+23
+0.6% +$1.07K ﹤0.01% 3667
2016
Q1 		$176K Sell
3,790
-62
-2% -$2.62K ﹤0.01% 3769
2015
Q4 		$161K Sell
3,852
-76
-2% -$3.19K ﹤0.01% 3782
2015
Q3 		$153K Hold
3,928
– – ﹤0.01% 3140
2015
Q2 		$198K Sell
3,928
-4
-0.1% -$205 ﹤0.01% 3772
2015
Q1 		$227K Sell
3,932
-7
-0.2% -$292 ﹤0.01% 3701
2014
Q4 		$144K Sell
3,939
-238
-6% -$7.01K ﹤0.01% 3855
2014
Q3 		$132K Buy
+4,177
New +$111K ﹤0.01% 3684
2014
Q2 		– Sell
-4,681
Closed -$139K – 3753
2014
Q1 		$139K Buy
4,681
+675
+17% +$26.3K ﹤0.01% 3703
2013
Q4 		$158K Buy
4,006
+2,986
+293% +$115K ﹤0.01% 3671
2013
Q3 		$107K Buy
+1,020
New +$125K ﹤0.01% 3717

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

Parametric Portfolio Associates's FBIO Position: Q1 2022 in Review

Parametric Portfolio Associates sold out of Fortress Biotech (FBIO) in Q1 2022, closing a stake of 2,345 shares — an estimated $88K sold.

Parametric Portfolio Associates first reported a position in FBIO in Q3 2013 and held it in 21 quarters. The position peaked at $281K in Q2 2017. 79 funds tracked by Wall St. Rank hold FBIO as of Q1 2022.

  • Parametric Portfolio Associates reported no remaining Fortress Biotech position as of Q1 2022 after selling out during the quarter.
  • Parametric Portfolio Associates sold 2,345 Fortress Biotech shares in Q1 2022, an estimated $88K.
  • Parametric Portfolio Associates first reported a position in Fortress Biotech in Q3 2013 and held it in 21 quarters.
  • Parametric Portfolio Associates's Fortress Biotech position peaked at $281K in Q2 2017.
  • 79 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.